| 摘要 |
The invention provides kappa receptor agonists of formula (I) and delta receptor antagonists of formula (II), wherein R<SUB>1</SUB>-R<SUB>6 </SUB>X and n have any of the meanings given in the specification, as well as compositions comprising them, methods for their use, and synthetic procedures and intermediates useful for their preparation.
|
